LUCD
Lucid Diagnostics Surpasses Q4 2025 Targets, Secures VA Contract for Esoguard
Lucid Diagnostics, a leading diagnostics company, has announced impressive results in its fourth quarter business update conference call. The company's EsoGuard test volume exceeded target ranges, with 3,664 tests conducted in Q4 2025, representing a 29% increase from the third quarter of 2025. Revenue for the same